Introduction
assay kits (Radim, Rome, Italy) . For all hormones, the intra-and interassay coefficents of variation were Ͻ14 and Ͻ9% respectively.
Antiphospholipid syndrome (APS) is a multisystem disease
Lupus anticoagulant was detected with a standard activated partial with the predominant clinical features of venous and arterial thromboplastin time (aPTT), a diluted phospholipid aPTT (Alving thrombosis, recurrent pregnancy loss, fetal death and the et al., 1985) , a kaolin clotting time (Exner et al., 1978) and tissue presence of antiphospholipid antibodies (aPL) (Love and thromboplastin inhibition test (Schleider et al., 1976) . Lupus anti- Santoro, 1990; McNeil et al., 1991) . Although it had been coagulant was defined by prolongation of coagulation times assumed that aPL are directed against anionic phospholipid (patient:control ratio of 1:3 or more) persisting after the addition of molecules, current advances in the field suggest that the control plasma (patient:control ratio 1:1) in at least two tests.
target antigens are phospholipid-binding proteins (Balestrieri Enzyme-linked immunosorbent assay (ELISA) et al., 1995) .
Several regimens have been proposed for the treatment of All the women selected were evaluated for the presence of aPL using the ELISA method as described by Harris (1990 Results were considered to be positive when the values were 5 SD (mIU/ml) above the mean control value obtained in a normal healthy population.
Follicle stimulating 3 5 3.5 3 2
To investigate possible interactions of heparin, acetylsalicylic acid hormone (mIU/ml) and betamethasone with aPL, we studied the effects of these drugs Gynecology Department of the Catholic University, Rome, Italy.
History of thrombosis no no yes no yes
Trophoblast cells were isolated and incubated as previously described Thrombocytopenia no no no no no (Di Simone et al., 1995) .
Anticardiolipin antibodies IgG and IgM no no yes yes yes Lupus anticoagulant no no yes yes no
Placental tissue was debrided of the membranes and decidua.
Venereal Disease Research Laboratory (VDRL) no no no no no
After mincing, the tissues were submitted to repeated enzymatic digestions in Ringer-bicarbonate buffer containing 0.25% trypsin-10
IU/ml DNase I at 37°C in a shaking water bath. Pooled cell supernatants were filtered through a 42 µM mesh filter and centrifuged Methylene blue assay in a 40% Percoll gradient for 20 min at 1200 g. After centrifugation
We used a colorimetric technique modified by Oliver et al. (1989) to two regions were identified: a bottom band containing red blood cells study cell number. The cells were grown in Dulbecco's modified and polymorphonuclear leukocytes and a middle band containing a Eagle's medium (DMEM) supplemented with 5% normal or aPL relatively uniform population of monuclear cells. serum in 96-well culture plates. Low molecular weight heparin Cell viability evaluated by Trypan Blue exclusion was Ͼ90%.
(200 IU/ml), betamethasone (50 nM) and acetylsalicylic acid (1.6 µM) Cell purity was determined by immunostaining for markers of were added at the time of plating to the three replicate wells. Cells syncytiotrophoblast (cytokeratin), fibroblasts (vimentin) and macrowere treated for 5 days with the same serum (patient 1 or 3) and phages [α 1 -antichrymotrypsin (ACT); Dako, Santa Barbara, CA, drug concentrations; the medium was changed every 24 h. On the USA] (Kliman et al., 1986) . fifth day, the culture medium in each well was removed. After The highly pure (95%) cytotrophoblast cells were counted and washing with 0.15% saline the cell layer was fixed by adding 100 µl volumes were adjusted, so that the cell concentration was 5ϫ10 5 of 10% formal saline to each well for at least 30 min. The fixative cells/ml/well. Cells were cultured at 37°C under 5% CO 2 and 95% was shaken off each plate and 100 µl of filtered 1% (w/v) Methylene air, in the presence of 5% human normal sera or 5% aPL-containing Blue in 0.01 M borate buffer (pH 8.5) was added to each well. After 30 min excess dye was removed and the remaining dye was then sera, with or without different concentrations of low molecular washed off with 0.01 M borate buffer. The absorbance at 650 nm weight heparin (0.5-200 IU/ml), acetylsalicylic acid (0.03-1.6 M) or (A 650) was measured from each well by a microplate photometer betamethasone (0.05-50 nM).
(Biorad platereader Model 405). The medium, the sera and the drugs were changed daily from day 1 of incubation. On day 5 of culture the cells were treated for 24 h with GnRH (Ferring; 10 -7 M). At the end of incubation the media
Results
were removed and stored at -20°C until assay for HCG. Table II summarizes clinical presentations and aPL specificities of the five women who provided sera for this study. The three 
heparin, acetylsalicylic acid and betamethasone
The results are expressed as the mean Ϯ SD of duplicate cultures.
Serum with elevated concentrations of aPL was assayed in the Statistical analysis was performed using two-way analysis of variance for multiple comparisons.
absence and with increasing amounts of heparin or low
APL-containing sera (patients 3, 4 and 5)
When GnRH was added to the culture medium pre-incubated with aPL-containing sera (Table III) , the HCG stimulation was abolished. Low molecular weight heparin appeared to restore the hormonal placental secretion. As shown in Table III the GnRH (10 -7 M) addition in placental cells cultured with low molecular weight heparin (25-200 IU/ml) increased HCG production in comparison with untreated (control) cells and with GnRH or heparin treatment alone (P Ͻ 0.05). Table IV shows that acetylsalicylic acid (0.03 µM) slightly increased GnRH-induced HCG secretion (P Ͻ 0.05). A higher dose (1.6 µM) reduced both basal and GnRH-induced HCG production.
Betamethasone increased basal and GnRH-induced HCG secretion in a dose-dependent way (Table V) , in both normal or aPL-containing sera treated cells. Its effect was significant at concentrations of 0.5 nM and above (P Ͻ 0.05), reaching a maximum at 50 nM (P Ͻ 0.01).
Methylene Blue assay
Since heparin, betamethasone and acetylsalicylic acid modified the placental HCG secretion, the effect of these drugs on cell number was investigated. Acetylsalicylic acid (1.6 µM) resulted in a significant inhibition of cell number (e.g. The reproductive history in patients with APS is characterized by recurrent spontaneous abortions, intrauterine growth retardation and stillbirths. A pathogenic mechanism has been postumolecular weight heparin (5-500 IU/ml) and the concentrations lated by several authors (Bulletti et al., 1996) . The majority were determined by ELISA (Figure 1) . A total of six experiof scientific evidence suggests a thrombotic tendency in this ments were performed.
syndrome. As shown in Figure 1 the inhibition of IgG anticardiolipin Another hypothesis proposed is that aPL have a detrimental binding was dose-dependent. Heparin did not significantly effect on the trophoblastic layer resulting in severe placental reduce the IgG binding from 5 to 100 IU/ml, whereas starting dysfunction and pregnancy loss. from 200 IU/ml the antibody binding significantly decreased Studies on human tissue and in mice suggest that aPL cause (P Ͻ 0.01). A pharmacological dose of low molecular weight pregnancy loss by binding to phospholipids expressed on the heparin (20 IU/ml) produced an inhibitory effect (P Ͻ 0.02), trophoblast, thereby inhibiting successful embryonic implantasimilar to a 10-fold higher heparin concentration (200 IU/ml; tion into the endometrium (Rai et al., 1997) . Heparin, in P Ͻ 0.01). Betamethasone and acetylsalicylic acid did not addition to its anticoagulant action, might act to reduce fetal cause any inhibition of aPL binding, as measured by ELISA.
loss by binding to aPL, thereby protecting the trophoblast phospholipids from attack and promoting successful implantaGnRH action on HCG secretion tion in early pregnancy (Rai et al., 1997) .
Normal sera (patients 1 and 2)
We found that, in vitro, heparin treatment of cytotrophoblast In agreement with our previous observation, the GnRH addition cells was able to restore the GnRH-induced HCG secretion, (10 -7 M) significantly increased HCG secretion (Table III) .
suggesting direct interference in the binding of aPL to cytoLow molecular weight heparin (0.5-200 IU/ml) and acetylsalitrophoblast-syncytiotrophoblast membranes. cylic acid (0.03-0.16 µM) did not modify either basal or Recently, Adler et al. (1994) provided direct evidence that GnRH-induced HCG production (Tables III and IV) ; whereas monoclonal aPL prevent intracellular fusion and differentiation a higher dose of acetylsalicylic acid (1.6 µM) reduces both of choriocarcinoma cells. In our system, the failure of placental cells to respond to GnRH might be due to reduced syncytium basal and GnRH-induced HCG secretion (Table IV) . formation. It is possible that the morphology and the differentimolecular weight heparin in the treatment of APS in pregnancy, because it causes less bleeding in both vaginal and abdominal ation state of the trophoblast is different between untreated cultures and heparin-treated cultures. Studies are ongoing to deliveries (Dulitzki et al., 1997) . The hormonal response (HCG) restored by low-dose aspirin investigate whether aPL can modify the differentiation of normal placental cells.
could open a new field of research. The dose of aspirin (0.03 µM) used in our experiments is close to the pharmacoFurthermore, low molecular weight heparin seems to be more effective at pharmacological and lower concentrations logical concentration that should be found in the plasma of low-dose (100 mg) aspirin-treated patients (Dekker and than regular heparin. Dawes et al. (1986) demonstrated that low molecular weight heparin may be more effective than Sibbai, 1993) . Low-dose aspirin might improve the pregnancy outcome in unfractionated heparin, because it is more effectively absorbed after s.c. administration and has a longer half-life in the women with aPL by irreversibly blocking the action of cyclooxygenase in platelets, thereby inhibiting platelet thromboxane circulation. According to our study, low molecular weight heparin has some advantage over heparin in having more synthesis and preventing thrombosis of the placental vasculature (Rai et al., 1997; Christiansen, 1996) . significant effects. This represents an important role for low
